NCT03122808

Brief Summary

Excessive uterine activity may be one of several aetiological factors that contribute to depressed neurological function in the newborn. During labour, uterine contractions can compress the fetal cranium at pressures high enough to impair cerebral perfusion. Contraction rates greater than 7 in 15 minutes are associated with an increased risk of neonatal encephalopathy. The American Congress of Obstetricians and Gynecologists defines uterine tachysystole as more than 5 contractions in 10 minutes, averaged over a 30-minute window. By this definition, excessive uterine activity is common and, at best, a non-specific predictor of depressed neurological function in the newborn. There is a need for predictors of neonatal encephalopathy that are more specific and clinically applicable. Contraction and relaxation duration are two measures that closely reflect the proposed role of excessive uterine activity in the pathogenesis of neonatal encephalopathy. Prolonged contractions with short relaxation periods result in progressive reductions in fetal cerebral oxygenation. Shorter uterine contraction periods are associated with an increased risk of low umbilical cord potential of hydrogen (pH) values. Our primary aim is to measure parameters of uterine activity, for example relaxation and contraction duration, and determine their relationship with the risk of neonatal encephalopathy. We will also investigate how measures of uterine activity interact with other measures of labour and fetal well-being, including cervical dilation rates and fetal heart rate patterns. In babies with neonatal encephalopathy, we will investigate the relationship of uterine activity with electrophysiological, radiological and developmental outcomes. We will perform a retrospective case-control study of babies born in the Rotunda hospital from 2005 until the present. The assessor of the Cardiotocograph (CTG) recordings will be blind to the disease status of the infants. For each recording, every uterine contraction and rest interval will be measured. Summary variables created from these measures will be used to compare the case and control groups. The primary variable will be mean rest interval duration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
264

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 21, 2017

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2021

Completed
Last Updated

May 22, 2023

Status Verified

May 1, 2023

Enrollment Period

4.3 years

First QC Date

April 18, 2017

Last Update Submit

May 19, 2023

Conditions

Keywords

TachysystoleExcessive Uterine Activity

Outcome Measures

Primary Outcomes (1)

  • Rest interval duration

    Expressed as mean, maximum, 90th centile. Individual uterine activity measures will be analysed both as continuous and categorised variables and in terms of minutes elapsed above a certain threshold that is to be determined.

    Whole CTG recording from start of labour to delivery

Secondary Outcomes (1)

  • Rest interval as a percentage of contraction-rest interval cycle

    Whole CTG recording from start of labour to delivery

Other Outcomes (3)

  • Contraction rate

    Whole CTG recording from start of labour to delivery

  • Contraction duration

    Whole CTG recording from start of labour to delivery

  • Excessive Uterine Activity Score

    Whole CTG recording from start of labour to delivery

Study Arms (2)

Neonatal encephalopathy

The inclusion criteria will be: * Moderate or severe neonatal encephalopathy * Gestational age of 35+0 weeks or greater * Singleton pregnancy * Inborn The exclusion criteria will be: * Non-hypoxic-ischaemic aetiology or postnatal hypoxic-ischaemia * Major congenital abnormalities * Less than 15 minutes of digital CTG recording from labour available

Diagnostic Test: Uterine Activity AnalysisDiagnostic Test: Partogram Analysis

Control

The inclusion criteria will be: * Gestational age of 35+0 weeks or greater * Singleton pregnancy * Inborn The exclusion criteria will be: * APGAR score of less than 5 at 1 minute or less than 7 at 5 or 10 minutes * Admission to the neonatal unit * Major congenital abnormalities * Less than 15 minutes of digital CTG recording from labour available

Diagnostic Test: Uterine Activity AnalysisDiagnostic Test: Partogram Analysis

Interventions

Analysis of components of uterine activity; contraction rate, length of contraction, length of relaxation and other values based off these measurements.

ControlNeonatal encephalopathy
Partogram AnalysisDIAGNOSTIC_TEST

Analysis of slope of partogram

ControlNeonatal encephalopathy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is babies born in the Rotunda hospital since 2005, when digital archiving of cardiotocographs began. The Rotunda Hospital is a level 3 maternity hospital located in Ireland with approximately 9,000 deliveries per year. The incidence of moderate or severe neonatal encephalopathy in the population is approximately one per 1000 births.

You may qualify if:

  • Moderate or severe neonatal encephalopathy
  • Gestational age of 35+0 weeks or greater
  • Singleton pregnancy
  • Inborn

You may not qualify if:

  • Non-hypoxic-ischaemic aetiology or postnatal hypoxic-ischaemia
  • Major congenital abnormalities
  • Less than 15 minutes of digital CTG recording from labour available Controls
  • Gestational age of 35+0 weeks or greater
  • Singleton pregnancy
  • Inborn
  • APGAR score of less than 5 at 1 minute or less than 7 at 5 or 10 minutes
  • Admission to the neonatal unit
  • Major congenital abnormalities
  • Less than 15 minutes of digital CTG recording from labour available

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Rotunda Hospital

Dublin, Co. Dublin, Ireland

Location

Study Officials

  • Breda Hayes, MD

    The Rotunda Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Neonatologist

Study Record Dates

First Submitted

April 18, 2017

First Posted

April 21, 2017

Study Start

September 1, 2016

Primary Completion

January 1, 2021

Study Completion

October 18, 2021

Last Updated

May 22, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations